Pfizer Inc. recalls 25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA,…
- Recall date
- November 27, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0577-2020
- FDA classification
- Class II
- Brand / firm
- Pfizer Inc.
- Sold / distributed
- Nationwide within the United States including Puerto Rico.
Why it was recalled
Labeling: Incorrect or Missing Lot and/or expiration date.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1775-10
Get recall alerts
Free email alert whenever Pfizer Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pfizer Inc.